Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of fospropofol, cyclopofol, and etomidate for anesthetic induction in elderly patients undergoing ureteroscopic lithotripsy
ChiCTR2200064737Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Zhengzhou University
- Start
- Oct 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fospropofol disodium, ciprofol and etomidate in ureterolithiasis (3 arms), sponsored by The Second Affiliated Hospital of Zhengzhou University. Primary endpoints: Heart rate, Systolic blood pressure and 3 more. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
fospropofol disodiumciprofoletomidate
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on ChiCTR2200064737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064737.